ANPI Insider Trading Activity and SEC Form 4 Filings
ANPI insider trading summary
No open-market insider purchases or sales of Angiotech Pharmaceuticals Inc (ANPI) have been reported on SEC Form 4 in the past 12 months.
Latest ANPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 26, 2010 | Jeffrey M Gross | SVP, Research & Development | Buy | $10K (9,000 @ $1.11) |
| Nov 20, 2009 | William L Hunter | President & CEO | Buy | $16K (11,100 @ $1.40) |
| Nov 20, 2009 | William L Hunter | President & CEO | Buy | $4K (3,000 @ $1.38) |
| Nov 20, 2009 | William L Hunter | President & CEO | Buy | $2K (1,500 @ $1.39) |
| Sep 29, 2009 | William L Hunter | President and CEO | Buy | $41K (21,600 @ $1.90) |
| Sep 29, 2009 | William L Hunter | President and CEO | Buy | $4K (2,200 @ $1.90) |
| Sep 29, 2009 | William L Hunter | President and CEO | Buy | $567 (300 @ $1.89) |
| Sep 29, 2009 | William L Hunter | President and CEO | Buy | $38K (20,000 @ $1.91) |
| Sep 29, 2009 | William L Hunter | President and CEO | Buy | $10K (5,400 @ $1.89) |
| Aug 27, 2009 | Jeffrey M Gross | SVP, Research & Development | Buy | $10K (6,000 @ $1.68) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.